Literature DB >> 14504125

Infrequent diagnosis of primary human immunodeficiency virus infection: missed opportunities in acute care settings.

Amy C Weintrob1, Julieta Giner, Prema Menezes, Ericka Patrick, Daniel Kelly Benjamin, Jeffrey Lennox, Christopher D Pilcher, Joseph J Eron, Charles B Hicks.   

Abstract

Although primary human immunodeficiency virus infection (PHI) is usually symptomatic and early management is likely important, the diagnosis is infrequently made. We examined a prospectively enrolled cohort of individuals diagnosed as having PHI in the southeastern United States to determine problems associated with the diagnosis of PHI. The following information was collected on each individual: site of initial presentation, number of visits to health care settings before diagnosis, diagnosing physician, alternative diagnoses, presumptive therapies, and time to diagnosis of PHI. Data were available for 29 of 30 patients (17 white, 12 nonwhite). Most patients were seen at least 3 times before the diagnosis of PHI was made. White persons were seen more frequently by primary care providers (P =.09). Nonwhite persons were diagnosed more quickly (P =.045). Only 5 patients (17%) were correctly diagnosed during their first encounter with the health care system, while 5 (17%) remained undiagnosed for more than 1 month after first presentation. Infectious diseases specialists diagnosed 83% of the cases. Human immunodeficiency virus is infrequently diagnosed during primary infection. More expeditious diagnosis of human immunodeficiency virus infection is a clinical and public health imperative.

Entities:  

Mesh:

Year:  2003        PMID: 14504125     DOI: 10.1001/archinte.163.17.2097

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  31 in total

1.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

2.  Escape from CD8(+) T cell responses in Mamu-B*00801(+) macaques differentiates progressors from elite controllers.

Authors:  Philip A Mudd; Adam J Ericsen; Benjamin J Burwitz; Nancy A Wilson; David H O'Connor; Austin L Hughes; David I Watkins
Journal:  J Immunol       Date:  2012-03-02       Impact factor: 5.422

3.  Primary HIV-1 Infection: Diagnosis, Pathogenesis, and Treatment.

Authors:  Malini Soogoor; Eric S Daar
Journal:  Curr Infect Dis Rep       Date:  2005-03       Impact factor: 3.725

4.  Acute HIV infection presenting as fulminant meningoencephalitis with massive CSF viral replication.

Authors:  Rosa M Andrade; Francesca J Torriani; Ronald J Ellis
Journal:  Neurol Clin Pract       Date:  2014-06

5.  Prevalence of primary HIV infection in symptomatic ambulatory patients.

Authors:  Andrew Coco; Emily Kleinhans
Journal:  Ann Fam Med       Date:  2005 Sep-Oct       Impact factor: 5.166

Review 6.  Primary human immunodeficiency virus type 1 infection.

Authors:  Malini Soogoor; Eric S Daar
Journal:  Curr HIV/AIDS Rep       Date:  2005-06       Impact factor: 5.071

Review 7.  Influenza and HIV: lessons from the 2009 H1N1 influenza pandemic.

Authors:  Anandi N Sheth; Pragna Patel; Philip J Peters
Journal:  Curr HIV/AIDS Rep       Date:  2011-09       Impact factor: 5.071

Review 8.  Acute HIV revisited: new opportunities for treatment and prevention.

Authors:  Christopher D Pilcher; Joseph J Eron; Shannon Galvin; Cynthia Gay; Myron S Cohen
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

9.  Diagnosis of acute HIV infection in Connecticut.

Authors:  Robert Dubrow; Kathleen J Sikkema; Kenneth H Mayer; R Douglas Bruce; Pamela Julian; Irma Rodriguez; Curt Beckwith; Aaron Roome; Dana Dunne; Alexandra Boeving; Thomas J Kidder; Heidi Jenkins; Michael Dobson; Joseph Becker; Michael H Merson
Journal:  Conn Med       Date:  2009 Jun-Jul

10.  Acute HIV-1 infection in the Southeastern United States: a cohort study.

Authors:  Mehri S McKellar; Anna B Cope; Cynthia L Gay; Kara S McGee; Joann D Kuruc; Melissa G Kerkau; Christopher B Hurt; Susan A Fiscus; Guido Ferrari; David M Margolis; Joseph J Eron; Charles B Hicks
Journal:  AIDS Res Hum Retroviruses       Date:  2012-09-04       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.